Total Payments
$4,806
2024 Payments
$1,636
Companies
24
Transactions
200
Medicare Patients
813
Medicare Billing
$82,148
Payment Breakdown by Category
Food & Beverage$4,759 (99.0%)
Education$46.91 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,759 | 199 | 99.0% |
| Education | $46.91 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $929.74 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $594.57 | 27 | $0 (2024) |
| ITI, Inc. | $534.06 | 27 | $0 (2023) |
| Axsome Therapeutics, Inc. | $421.98 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $358.77 | 21 | $0 (2024) |
| ABBVIE INC. | $354.51 | 20 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $325.33 | 17 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $276.93 | 13 | $0 (2024) |
| Lundbeck LLC | $169.79 | 10 | $0 (2024) |
| MML US, Inc. | $154.66 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,636 | 68 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($325.33) |
| 2023 | $1,400 | 65 | ITI, Inc. ($356.49) |
| 2022 | $888.24 | 32 | Alkermes, Inc. ($252.37) |
| 2021 | $881.72 | 35 | Alkermes, Inc. ($333.74) |
All Payment Transactions
200 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: CNS | ||||||
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $11.46 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $121.60 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Insomnia | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $105.10 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: PSYCHIATRY | ||||||
| 10/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $97.88 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Neuroscience | ||||||
| 10/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Central Nervous System | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $113.88 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Neuropsychiatry | ||||||
| 09/13/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/10/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 100 | 299 | $58,496 | $18,166 |
| 2022 | 5 | 178 | 307 | $44,446 | $11,825 |
| 2021 | 5 | 258 | 614 | $73,750 | $29,222 |
| 2020 | 4 | 277 | 631 | $74,695 | $22,934 |
Total Patients
813
Total Services
1,851
Medicare Billing
$82,148
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 231 | $45,322 | $15,743 | 34.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 23 | 23 | $12,310 | $2,341 | 19.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 22 | 45 | $864.00 | $82.93 | 9.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 94 | $15,150 | $4,994 | 33.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 33 | 33 | $16,982 | $3,915 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 58 | $7,038 | $1,448 | 20.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 35 | $3,675 | $1,224 | 33.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 21 | 87 | $1,601 | $244.76 | 15.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 184 | $22,080 | $10,671 | 48.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 256 | $30,720 | $9,917 | 32.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 51 | 131 | $13,755 | $5,771 | 42.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 22 | $3,520 | $1,891 | 53.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 20 | 21 | $3,675 | $972.51 | 26.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 127 | 358 | $43,080 | $10,681 | 24.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 40 | 127 | $13,335 | $5,992 | 44.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 85 | $10,200 | $3,624 | 35.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 19 | $3,040 | $1,698 | 55.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 26 | 29 | $3,480 | $642.79 | 18.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 12 | 13 | $1,560 | $296.48 | 19.0% |
About Tiffany Chaille
Tiffany Chaille is a Psychiatric/Mental Health healthcare provider based in Roanoke, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2016. The National Provider Identifier (NPI) number assigned to this provider is 1932655982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tiffany Chaille has received a total of $4,806 in payments from pharmaceutical and medical device companies, with $1,636 received in 2024. These payments were reported across 200 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,759).
As a Medicare-enrolled provider, Chaille has provided services to 813 Medicare beneficiaries, totaling 1,851 services with total Medicare billing of $82,148. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health, Psychiatric/Mental Health
- Location Roanoke, VA
- Active Since 08/30/2016
- Last Updated 01/12/2026
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1932655982
Products in Payments
- CAPLYTA (Drug) $859.39
- LYBALVI (Drug) $479.46
- REXULTI (Drug) $434.18
- ARISTADA (Drug) $427.82
- Auvelity (Drug) $404.33
- VRAYLAR (Drug) $354.51
- INVEGA SUSTENNA (Drug) $324.56
- ABILIFY MAINTENA (Drug) $210.62
- AUSTEDO (Drug) $189.60
- ReActiv8 (Device) $154.66
- COBENFY (Drug) $133.06
- ABILIFY ASIMTUFII (Drug) $99.48
- Azstarys (Drug) $68.70
- Austedo XR (Drug) $57.50
- QUVIVIQ (Drug) $52.76
- INGREZZA (Drug) $51.21
- FANAPT (Drug) $48.24
- TRINTELLIX (Drug) $41.47
- Dyanavel XR (Drug) $40.20
- Superion Indirect Decompression System (Device) $37.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Roanoke
Stephanie Sylvester-Johnson, Rn, Pmhnp-Bc, RN, PMHNP-BC
Psychiatric/Mental Health — Payments: $2,219
Psychiatric/Mental Health $2,219
Melinda Luckay, Crnp, CRNP
Psychiatric/Mental Health — Payments: $1,774
Psychiatric/Mental Health $1,774
Michie Bolden, Np, NP
Psychiatric/Mental Health — Payments: $1,244
Psychiatric/Mental Health $1,244
William White, Rn, Pmhnp, RN, PMHNP
Psychiatric/Mental Health — Payments: $666.89
Psychiatric/Mental Health $666.89
Cozetta Hubbard
Psychiatric/Mental Health — Payments: $277.83
Psychiatric/Mental Health $277.83
Maria Brickner, Arnp, Pmhnp-Bc, ARNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $268.29
Psychiatric/Mental Health $268.29